These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 25660153)

  • 1. Shedding light on in-stent restenosis: are bioresorbable vascular scaffolds the solution for a vexing problem?
    van Ditzhuijzen NS; Regar E
    Can J Cardiol; 2015 Mar; 31(3):253-4. PubMed ID: 25660153
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of bioresorbable scaffold and optical coherence tomography in the treatment of recurrent in-stent restenosis: a case report].
    Mattesini A; Dall'Ara G; Rama-Merchan JC; Ghione M; Foin N; Secco GG; Di Mario C
    G Ital Cardiol (Rome); 2013 Dec; 14(12):836-8. PubMed ID: 24336600
    [No Abstract]   [Full Text] [Related]  

  • 3. Recurrent Neoatherosclerosis After Bioresorbable Vascular Scaffold Treatment of In-Stent Restenosis.
    Bastante T; Rivero F; Benedicto A; Cuesta J; Alfonso F
    JACC Cardiovasc Interv; 2015 Aug; 8(9):1264-1265. PubMed ID: 26292592
    [No Abstract]   [Full Text] [Related]  

  • 4. Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel.
    Naganuma T; Costopoulos C; Latib A; Sato K; Miyazaki T; Colombo A
    JACC Cardiovasc Interv; 2014 May; 7(5):e45-6. PubMed ID: 24746654
    [No Abstract]   [Full Text] [Related]  

  • 5. Bioresorbable vascular scaffold implantation for treatment of recurrent in-stent restenosis: insights from optical coherence tomography.
    Camuglia AC; Lavi S
    Int J Cardiol; 2014 Mar; 172(1):238-9. PubMed ID: 24447733
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of in-stent restenosis with bioresorbable vascular scaffolds: optical coherence tomography insights.
    Rivero F; Bastante T; Cuesta J; Benedicto A; Restrepo JA; Alfonso F
    Can J Cardiol; 2015 Mar; 31(3):255-9. PubMed ID: 25660152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of coronary in-stent restenosis with bioabsorbable vascular scaffolds.
    Alfonso F; Nuccio J; Cuevas C; Cárdenas A; Gonzalo N; Jimenez-Quevedo P
    J Am Coll Cardiol; 2014 Jul; 63(25 Pt A):2875. PubMed ID: 24969756
    [No Abstract]   [Full Text] [Related]  

  • 8. Neointimal proliferation is associated with clinical restenosis 2 years after fully bioresorbable vascular scaffold implantation.
    Indolfi C; Mongiardo A; Spaccarotella C; Caiazzo G; Torella D; De Rosa S
    Circ Cardiovasc Imaging; 2014 Jul; 7(4):755-7. PubMed ID: 25027457
    [No Abstract]   [Full Text] [Related]  

  • 9. In-stent restenosis because of nickel hypersensitivity: a bioresorbable solution?
    Granata F; Moscarella E; Varricchio A
    Coron Artery Dis; 2015 Aug; 26(5):461-2. PubMed ID: 25816019
    [No Abstract]   [Full Text] [Related]  

  • 10. Late-acquired scaffold malapposition and discontinuity that may be attributable to pathological coronary ectasia: Insights from optical coherence tomography.
    Miyazaki T; Ruparelia N; Kawamoto H; Sato K; Latib A; Colombo A
    Int J Cardiol; 2015; 186():136-8. PubMed ID: 25818756
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of coronary stent restenosis with drug-eluting bioabsorbable magnesium scaffolds.
    Alfonso F; Cuesta J; García-Guimaraes M; Bastante T; Maruri R; Rivero F
    Coron Artery Dis; 2017 Nov; 28(7):627-628. PubMed ID: 28644215
    [No Abstract]   [Full Text] [Related]  

  • 12. Subacute thrombosis of a bioresorbable vascular scaffold implanted for recurrent in-stent restenosis.
    Rivero F; Benedicto A; Bastante T; Cuesta J; Diego G; Alfonso F
    EuroIntervention; 2015 Nov; 11(7):780. PubMed ID: 25308302
    [No Abstract]   [Full Text] [Related]  

  • 13. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
    Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW
    JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-in-human description of everolimus-eluting bioabsorbable vascular scaffold implantation for the treatment of drug-eluting stent failure: insights from optical coherence tomography.
    Grasso C; Attizzani GF; Patané M; Ohno Y; Capodanno D; Tamburino C
    Int J Cardiol; 2013 Oct; 168(4):4490-1. PubMed ID: 23890924
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyphering the mechanism of late failure of bioresorbable vascular scaffolds in percutaneous coronary intervention of the left main coronary artery.
    Gargiulo G; Longo G; Capodanno D; Francaviglia B; Capranzano P; Tamburino C
    JACC Cardiovasc Interv; 2015 May; 8(6):e95-e97. PubMed ID: 25999117
    [No Abstract]   [Full Text] [Related]  

  • 16. Very late acquired peri-stent contrast staining and incomplete stent apposition with biodegradable polymer stents: insight from optical coherence tomography.
    Takashima H; Sakurai S; Waseda K; Kurita A; Ando H; Kumagai S; Amano T
    Int J Cardiol; 2014 Sep; 176(1):e11-2. PubMed ID: 25085382
    [No Abstract]   [Full Text] [Related]  

  • 17. Delayed disruption of a bioresorbable vascular scaffold.
    Naganuma T; Latib A; Panoulas VF; Sato K; Miyazaki T; Colombo A
    JACC Cardiovasc Imaging; 2014 Aug; 7(8):845-7. PubMed ID: 25124018
    [No Abstract]   [Full Text] [Related]  

  • 18. First reported use of drug-coated balloon for bioresorbable in-scaffold restenosis.
    Latini RA; Buccheri D; Cortese B
    Catheter Cardiovasc Interv; 2017 Mar; 89(4):676-678. PubMed ID: 27649683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful use of bioresorbable vascular scaffold in in-stent restenosis previously exposed to vascular brachytherapy.
    Wong KL; Fan KY; Jim MH
    Int J Cardiol; 2015 Feb; 181():1-2. PubMed ID: 25473779
    [No Abstract]   [Full Text] [Related]  

  • 20. Late stent thrombosis after the use of a bioresorbable vascular scaffold for the treatment of in-stent restenosis.
    Lee WC; Fang HY; Fang CY
    Coron Artery Dis; 2016 Dec; 27(8):709-710. PubMed ID: 27379437
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.